* Health Catalyst Inc HCAT.OQ reported quarterly adjusted
earnings of 5 cents per share for the quarter ended in March,
identical to the same quarter last year. The mean expectation
of fifteen analysts for the quarter was for earnings of 3 cents
per share. Wall Street expected results to range from -6 cents
to 6 cents per share.
* Revenue rose 1.2% to $74.72 million from a year ago;
analysts
expected $74.80 million.
* Health Catalyst Inc's reported EPS for the quarter was a
loss
of 35 cents.
* The company reported a quarterly loss of $20.59 million.
* Health Catalyst Inc shares had fallen by 11.7% this
quarter and
lost 28.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 6% in
the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the software peer
group
is also "buy"
Wall Street's median 12-month price target for Health Catalyst
Inc is $11.50
This summary was machine generated from LSEG data May 9 at 10:39
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 0.03 0.05 Beat
Dec. 31 2023 0.00 0.02 Beat
Sep. 30 2023 -0.02 0.03 Beat
Jun. 30 2023 0.00 0.05 Beat